Open AccessNomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
Author(s) -
Fang-Ze Wei,
Shiwen Mei,
Jianan Chen,
Zhijie Wang,
Huan Shen,
Juan Li,
Fen Zhao,
Zheng Liu,
Qian Liu
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i42.6638
Subject(s) - nomogram , medicine , carcinoembryonic antigen , colorectal cancer , oncology , proportional hazards model , neoadjuvant therapy , receiver operating characteristic , colectomy , stage (stratigraphy) , t stage , cancer , surgery , breast cancer , paleontology , biology
Colorectal cancer is a common digestive cancer worldwide. As a comprehensive treatment for locally advanced rectal cancer (LARC), neoadjuvant therapy (NT) has been increasingly used as the standard treatment for clinical stage II/III rectal cancer. However, few patients achieve a complete pathological response, and most patients require surgical resection and adjuvant therapy. Therefore, identifying risk factors and developing accurate models to predict the prognosis of LARC patients are of great clinical significance.